Abstract | BACKGROUND: DESIGN: We evaluated 87 unselected consecutive HIV-1 infected patients for the presence of cryoglobulinemia and they were prospectively followed up for a median of 34 months, with clinic visits at 4-month intervals. None of the patients had neoplasia at study entry. Time-to-event analysis for death, neoplasm and B-cell lymphoproliferative disorder were performed with Cox proportional hazards models. RESULTS: Mixed cryoglobulinemia (types II and III) was detected in 24 (28%) of the 87 patients. During the follow up, 12 patients died and 8 developed neoplastic disease. Multivariate analysis showed that circulating cryoglobulins were an independent predictor of death [relative risk (RR), 4.97; 95% confidence intervals (CI), 1.26-19.63] and development of neoplasia (RR, 5.18; 95% CI, 1.23-21.83). In addition, cryoglobulinemia reached borderline significance as a predictor of lymphoproliferative disorder of B-cell origin (P = 0.08; RR, 4.53; 95% CI, 0.83-24.75). CONCLUSIONS:
|
Authors | T Kordossis, N V Sipsas, A Kontos, U Dafni, H M Moutsopoulos |
Journal | European journal of clinical investigation
(Eur J Clin Invest)
Vol. 31
Issue 12
Pg. 1078-82
(Dec 2001)
ISSN: 0014-2972 [Print] England |
PMID | 11903495
(Publication Type: Journal Article)
|
Topics |
- Adult
- Cryoglobulinemia
(mortality, virology)
- Female
- HIV Infections
(complications, mortality, virology)
- HIV-1
- Humans
- Lymphoma, B-Cell
(mortality, virology)
- Lymphoproliferative Disorders
(mortality, virology)
- Male
- Middle Aged
- Neoplasms
(mortality, virology)
- Predictive Value of Tests
- Prospective Studies
- Risk Factors
- Survival Analysis
|